About the job
Axsome Therapeutics focuses on developing and delivering treatments for central nervous system (CNS) disorders. The company’s mission centers on closing care gaps and advancing therapies that improve patient outcomes for serious neurological and psychiatric conditions.
The current portfolio includes FDA-approved options for major depressive disorder, narcolepsy-related excessive daytime sleepiness, obstructive sleep apnea, and migraines. Additional programs target a range of CNS conditions that affect millions in the United States.
Company highlights
- Specializes in brain health and CNS therapies
- Offers approved treatments and maintains a strong development pipeline
- Focuses on conditions impacting over 150 million people nationwide
Learn more about Axsome Therapeutics at www.axsome.com or visit their LinkedIn page.
